Evidence map›Paper›PMID 42007838›Full record

ArticleJournal of clinical microbiology2026

Yeast identification, antifungal susceptibility testing, and

Jeremy A W Gold, Kaitlin Benedict, Kathryn A Haass, Hemjot Kaur, Pranjal Muthe, Beth A Bouwkamp, Meghan Lyman, Mitsuru Toda, Tiffany Rivers, Shawn R Lockhart

Abstract read
In one paragraph

Article in Journal of clinical microbiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Surveillance for Candida auris - United States, 2022-2024.Morbidity and mortality weekly report. Surveillance summaries (Washington, D.C. : 2002) · 2026
    Article
  2. Frontiers in cellular and infection microbiology · 2026
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Jeremy A W GoldMycotic Diseases Branch, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.ORCID 0000-0002-5054-7616
Kaitlin BenedictMycotic Diseases Branch, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
Kathryn A HaassDivision of Healthcare Quality Promotion, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
Hemjot KaurDivision of Healthcare Quality Promotion, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
Pranjal MutheDivision of Healthcare Quality Promotion, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
Beth A BouwkampCACI International Inc, Atlanta, Georgia, USA.
Meghan LymanMycotic Diseases Branch, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
Mitsuru TodaMycotic Diseases Branch, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
Tiffany RiversMycotic Diseases Branch, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
Shawn R LockhartMycotic Diseases Branch, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.ORCID 0000-0002-4383-5994

Funding

Intramural CDC HHS CC999999
6 · The paper itself

Abstract

Accurate species identification and antifungal susceptibility testing (AFST) are critical for detection and clinical management of emerging antifungal-resistant yeasts such as IMPORTANCE: Accurate yeast identification and antifungal susceptibility testing (AFST) are important for detecting and managing drug-resistant fungi, particularly

Indexed as

Antifungal AgentsCandidaCandida aurisCandidiasisMass ScreeningHospitalsHumansMicrobial Sensitivity TestsSpectrometry, Mass, Matrix-Assisted Laser Desorption-IonizationUnited StatesAntifungal Agentsantifungal susceptibility testingCandida aurishealthcare-associated infectionslong-term acute care hospitalsMALDI-TOF MSNational Healthcare Safety Networkspecies identificationyeast identification

Identifiers

PMID42007838
PMCPMC13153474

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.